. Author manuscript; available in PMC: 2019 Mar 1.

Published in final edited form as: Transplantation. 2018 Mar;102(3):502–509. doi: 10.1097/TP.0000000000001944

Table 2B.

Comparisons of adverse outcome of heart transplantation by DSA strength in MFI.

					p value^a
Adverse Outcome Variable	No DSA (N=68)	DSA MFI ≥ 7000 (N=33)	DSA MFI <7000 (N=26)	All patients (N=127)	All patients	No DSA vs DSA MFI ≥7000	No DSA vs DSA MFI < 7000	DSA MFI <7000 vs ≥7000
Acute rejections per patient-year	0.5±0.9	2.0±1.4	1.0±1.1	0.9±1.3	<0.0001†	<0.0001§	<0.0372§	0.0059§
CAV	8 (11.7%)	17 (51.5%)	7 (26.9%)	32 (25.1%)	0.0001	0.0002	0.107*	0.1749
Graft loss^#	12 (17.6%)	10 (39.3%)	5 (19.2%)	27 (21.2%)	0.56	0.282	0.722	0.594

Graft loss due to CAV and/or acute rejections is only used in this analysis.

Note:

† by ANOVA; § by t test; * by Fisher’s Exact Test; Otherwise by Chi Square Test